triptorelin pamoate · Verity · NDA 020715, 021288, 022437
Trelstar
Earliest generic entry, as listed · earliest of 3 marketed strengths
30 Jun 2029
2 of 3 marketed strengths have no unexpired patent or exclusivity listed.
Blocked by patent: US 10166181.
Listed patents · 1 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 10166181 | drug product · sets the listed date | 30 Jun 2029 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 3
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 020715 · 001 · RLD | injectable, intramuscular | EQ 3.75MG BASE/VIAL | open |
| 021288 · 001 · RLD | injectable, intramuscular | EQ 11.25MG BASE/VIAL | open |
| 022437 · 001 · RLD | injectable, intramuscular | EQ 22.5MG BASE/VIAL | 30 Jun 2029 |